.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Chubb
Merck
Chinese Patent Office
US Department of Justice
Federal Trade Commission
US Army
QuintilesIMS
Colorcon

Generated: December 15, 2017

DrugPatentWatch Database Preview

DEPOCYT Drug Profile

« Back to Dashboard

Which patents cover Depocyt, and when can generic versions of Depocyt launch?

Depocyt is a drug marketed by Pacira Pharms Inc and is included in one NDA.

The generic ingredient in DEPOCYT is cytarabine. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cytarabine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DEPOCYT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
Pacira Pharms IncDEPOCYTcytarabineINJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
Baxter
Teva
Johnson and Johnson
Covington
Dow
Accenture
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot